Teresa Gragera

Teresa Gragera

Auto-generated profile, based on publicly available information

Teresa Gragera


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
COCristina Obispo
Cristina Obispo
TGTeresa Gragera
Teresa Gragera
GGGiovanni Giovannini
Giovanni Giovannini
ÁZÁlvaro Zubizarreta-Macho
Álvaro Zubizarreta-Macho
JLJuan Manuel Aragoneses Lamas
Juan Manuel Aragoneses Lamas
The aim of this work was to analyze and compare the tooth structure removal between a free-hand preparation technique and a computer-aided preparation technique using an augmented reality appliance for complete-crowns preparation designs and “root mean square” (RMS) alignment value. Ten upper teeth representatives of all dental sectors were selected from a generic model library as “Standard Tessellation Language” (STL-1) digital files and 3D-printed in an anatomically based acrylic resin experimental model. Then these were randomly assigned to the following tooth preparation techniques: Group A: free-hand preparation technique (n = 5) (FHT) and Group B: computer-aided preparation technique using an augmented reality appliance (n = 5) (AR). Experimental models were submitted to a digital impression through an intraoral scan and (STL-2) uploaded into a reverse engineering morphometric software to measure the volumetric reduction in the planned and performed tooth structure (mm3) and RMS using the Student’s t-test and the Mann–Whitney non-parametric test. Statistically significant differences were observed between the volumetric reduction in the planned and performed tooth structure (mm3) of the AR and FHT study groups (p = 0.0001). Moreover, statistically significant differences were observed between the RMS of the planned and performed tooth preparations in both the AR and FHT study groups (p = 0.0005). The augmented reality appliance provides a more conservative and predictable complete-crowns preparation design than the free-hand preparation technique.

12 April 2023 in Oncogenesis
Verified
Journal Article
Open access
PDF file
NMNatalia Martínez
Natalia Martínez
TGTeresa Gragera
Teresa Gragera
MLMaría Pilar de Lucas
María Pilar de Lucas
ACAna Belén Cámara
Ana Belén Cámara
ABAlicia Ballester
Alicia Ballester
JRJosé M. Rojas-Cabañeros
José M. Rojas-Cabañeros
Spry2 is a molecular modulator of tyrosine kinase receptor signaling pathways that has cancer-type-specific effects. Mammalian Spry2 protein undergoes tyrosine and serine phosphorylation in response to growth factor stimulation. Spry2 expression is distinctly altered in various cancer types. Inhibition of the proteasome functionality results in reduced intracellular Spry2 degradation. Using in vitro and in vivo assays, we show that protein kinase D (PKD) phosphorylates Spry2 at serine 112 and interacts in vivo with the C-terminal half of this protein. Importantly, missense mutation of Ser112 decreases the rate of Spry2 intracellular protein degradation. Either knocking down the expression of all three mammalian PKD isoforms or blocking their kinase activity with a specific inhibitor contributes to the stabilization of Spry2 wild-type protein. Downregulation of CSN3, a component of the COP9/Signalosome that binds PKD, significantly increases the half-life of Spry2 wild-type protein but does not affect the stability of a Spry2 after mutating Ser112 to the non-phosphorylatable residue alanine. Our data demonstrate that both PKD and the COP9/Signalosome play a significant role in control of Spry2 intracellular stability and support the consideration of the PKD/COP9 complex as a potential therapeutic target in tumors where Spry2 expression is reduced.